Analyst Coverage Updates: July 3rd, 2025
Analyst Ratings (USA) 4D Molecular Therapeutics (FDMT) is rated a Buy with a $25.00 target reiterated by Chardan Capital. Absci (ABSI) is…
Browse research
Analyst Ratings (USA) 4D Molecular Therapeutics (FDMT) is rated a Buy with a $25.00 target reiterated by Chardan Capital. Absci (ABSI) is…
Analyst Updates (Canada) Advantage Energy Ltd. (AAV:CA) had its price target raised to $12.00 by RBC Capital Markets, with the firm maintaining…
AltaGas Ltd. (ALA:CA) (ATGPF) AltaGas Ltd. is a Canadian energy infrastructure company operating in two main segments: utilities and midstream (natural gas…
Trending Stocks These stocks are currently trending as analysts have recently updated their coverage and outlook on these companies based on specific…
Alimentation Couche-Tard Inc. (ATD:CA (ANCTF) Alimentation Couche-Tard Inc. is a Canadian multinational convenience store operator headquartered in Laval, Quebec. Founded in 1980 by…